Form N-CSR/A - Certified Shareholder Report: [Amend]
SEC Accession No. 0000930413-06-003688
Filing Date
2006-05-10
Accepted
2006-05-10 11:42:05
Documents
3
Period of Report
2005-10-31
Effectiveness Date
2006-05-10

Document Format Files

Seq Description Document Type Size
1 c42455_n-csra.txt N-CSR/A 10658
2 c42455_ex99-cert.txt EX-99.CERT 7189
3 c42455_ex99-906cert.txt EX-99.906CERT 1269
  Complete submission text file 0000930413-06-003688.txt   21939

Series and Classes/Contracts Information:

Existing
  Status Name Ticker Symbol
CIK 0000003521      
Series S000009164   Alger Health Sciences Fund
Class/Contract C000024915   Alger Health Sciences Fund Class A AHSAX
Class/Contract C000024916   Alger Health Sciences Fund Class B AHSBX
Class/Contract C000024917   Alger Health Sciences Fund Class C AHSCX
  Status Name Ticker Symbol
CIK 0000003521      
Series S000009165   Alger SmallCap and MidCap Growth Fund
Class/Contract C000024918   Alger SmallCap and MidCap Growth Fund Class A ALMAX
Class/Contract C000024919   Alger SmallCap and MidCap Growth Fund Class B ALMBX
Class/Contract C000024920   Alger SmallCap and MidCap Growth Fund Class C ALMCX
Mailing Address 30 MONTGOMERY STREET 13TH FLOOR JERSEY CITY NJ 07302
Business Address 111 FIFTH AVENUE NEW YORK NY 10003 2128068800
ALGER FUNDS (Filer) CIK: 0000003521 (see all company filings)

EIN.: 000000000 | State of Incorp.: MA | Fiscal Year End: 1031
Type: N-CSR/A | Act: 40 | File No.: 811-01355 | Film No.: 06824225